Faculty profile

Benedikt Fischer

ResearcherSocial, Prevention and Health Policy ResearchUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Benedikt Fischer

Researcher

Social, Prevention and Health Policy Research

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
55 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 14 research grants (12 CIHR, 1 SSHRC, 1 NSERC), most recently in 2017.
Supervisor on 1 trainee award (1 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

168

Publications

155

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Policy Prevention Treatment Evidence-Based Interventions Crisis Health Services Intervention Science

Latest papers

Might cannabis Legalization Have Affected Public Health-Relevant Alcohol- and Tobacco-use Outcomes in Canada?
Nordisk alkohol- & narkotikatidskrift : NAT · 2026 · first author
Recent decreases in drug overdose deaths: Assessing evidence for supply-related drivers and implications for health-oriented drug policy in Canada.
Preventive medicine · 2026 · first author
Cannabis Legalization Outcomes in Canada: Trading Off Increased Health Problem for Reduced Crime Burdens Is Not Good Enough.
Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026 · first author

All 168 publications

Latest funding

Evaluating the intended and unintended consequences of opioid prescribing interventions on primary care
CIHR · 2021 · Co-investigator
$371,024
CRISM Implementation Science Program on Opioid Interventions and Services - Ontario OCRINT
CIHR · 2017 · Nominated PI
$1,875,000
Provincial and key community responses to federal cannabis legalization: A multi-jurisdictional study
CIHR · 2017 · Co-investigator
$100,000

All 23 grants and awards

From the 150 most recent of 168 publications.

Might cannabis Legalization Have Affected Public Health-Relevant Alcohol- and Tobacco-use Outcomes in Canada?

Fischer B, Hall W, Jutras-Aswad D, Le Foll B

Nordisk alkohol- & narkotikatidskrift : NAT2026First author

DOI: 10.1177/14550725261488522 PMID: 42763468

Recent decreases in drug overdose deaths: Assessing evidence for supply-related drivers and implications for health-oriented drug policy in Canada.

Fischer B, Hall W

Preventive medicine2026First author

DOI: 10.1016/j.ypmed.2026.108607 PMID: 42155639

Cannabis Legalization Outcomes in Canada: Trading Off Increased Health Problem for Reduced Crime Burdens Is Not Good Enough.

Fischer B, Hall W, Jutras-Aswad D, Le Foll B, Myran DT

Canadian journal of psychiatry. Revue canadienne de psychiatrie2026First author

DOI: 10.1177/07067437261454772 PMID: 42159427

Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada's federal correctional system.

Russell C, George TP, Chopra N, Le Foll B, Matheson FI, Kolla G, Wyman J, Fischer B, Bozinoff N, Rehm J, Lange S

Canadian journal of public health = Revue canadienne de sante publique2026

DOI: 10.17269/s41997-026-01186-x PMID: 41954885

Outcomes and implications of British Columbia's 'drug decriminalization initiative' for health-oriented drug policymaking.

Fischer B, Jutras-Aswad D, Le Foll B, Myran DT

The International journal on drug policy2026First author

DOI: 10.1016/j.drugpo.2026.105181 PMID: 41653487

Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution.

Matsukubo J, Friesen EL, MacDonald-Spracklin R, Iseman R, Solmi M, Fiedorowicz JG, Fischer B, Myran DT

Canadian journal of public health = Revue canadienne de sante publique2026

DOI: 10.17269/s41997-026-01178-x PMID: 41857461

Online promotional practices and apparent violations from licensed cannabis retail stores in Canada.

MacDonald-Spracklin R, Waqar A, Islam A, Fischer B, Crépault JF, Thompson K, Myran DT

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2026.105350 PMID: 42259170

'Strategic approaches to reducing the substance use-related burden of disease in Canada' - authors' reply.

Fischer B, Hall W, Le Foll B, Conrod P

Lancet regional health. Americas2026First author

DOI: 10.1016/j.lana.2026.101376 PMID: 41657494

Public health impacts of legalizing recreational cannabis use in Canada and the US.

Hall W, Fischer B

World psychiatry : official journal of the World Psychiatric Association (WPA)2026Senior author

DOI: 10.1002/wps.70030 PMID: 41536106

Correlates of Engagement and Associations With Outcomes in a Cannabis Harm-Reduction Mobile App for Youth With First-Episode Psychosis: Exploratory Analysis of the CHAMPS Pilot Randomized Controlled Trial.

Mahroug A, Lachance-Touchette P, Coronado-Montoya S, Abdel-Baki A, Côté J, Crocker C, Crockford DN, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lecomte T, L'Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D

JMIR formative research2026

DOI: 10.2196/84836 PMID: 42550986

Something wrong or missing on this profile? Suggest a correction

Benedikt Fischer

Research

Latest papers

Latest funding

Might cannabis Legalization Have Affected Public Health-Relevant Alcohol- and Tobacco-use Outcomes in Canada?

Recent decreases in drug overdose deaths: Assessing evidence for supply-related drivers and implications for health-oriented drug policy in Canada.

Cannabis Legalization Outcomes in Canada: Trading Off Increased Health Problem for Reduced Crime Burdens Is Not Good Enough.

Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada's federal correctional system.

Outcomes and implications of British Columbia's 'drug decriminalization initiative' for health-oriented drug policymaking.

Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution.

Online promotional practices and apparent violations from licensed cannabis retail stores in Canada.

'Strategic approaches to reducing the substance use-related burden of disease in Canada' - authors' reply.

Public health impacts of legalizing recreational cannabis use in Canada and the US.

Correlates of Engagement and Associations With Outcomes in a Cannabis Harm-Reduction Mobile App for Youth With First-Episode Psychosis: Exploratory Analysis of the CHAMPS Pilot Randomized Controlled Trial.

Frequent collaborators

Bernard Le Foll

Didier Jutras-Aswad

Paul Kurdyak

Evan Wood

Michael Roerecke

Elliot Goldner

Peter Selby

Michelle Firestone

Amal Abdel-Baki

Tara Gomes

Marco Solmi

Keith Ahamad

Laurel Challacombe

Ted Myers

David Rudoler

Dolly Baliunas

Carol Strike

Joanna Henderson

Shaun Hopkins

Patricia Conrod

Tania Lecomte

Bundit Sornpaisarn

Jennifer Wyman

Benoît Mâsse

Thomas Kerr

Jeffrey Brubacher

David Lloyd Streiner

Gina Ogilvie

Susan Jack

Lydia Kapiriri

Frances Tse